glp-1s with compounded semaglutide GLP-1 Drugs from the Gray Market GLP-1s | AgelessRx

GLP-1 Pipeline Update: May 2025 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid

The immense telehealth and compounding boom of these medications due to shortage led to an unpredictable, and at times less than safe, environment for providers and patients alike

Christian Hendershot, director of clinical research at the USC Institute for Addiction Science, who wasnt involved in the new research but has run trials of GLP-1s in addiction

However, we believe Lilly may be able to close the gap fast, once its own oral obesity pill, orforglipron is approved by the FDA in 2026

If your exact vial and water combination is not listed, run it through the free retatrutide calculator for the precise units